Cocrystal Pharma
COCP
#10259
Rank
A$20.26 M
Marketcap
A$1.47
Share price
-0.93%
Change (1 day)
-65.82%
Change (1 year)

Earnings for Cocrystal Pharma (COCP)

Earnings in 2025 (TTM): -A$15.31 Million

According to Cocrystal Pharma 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$26.81 Million, an increase over its 2023 earnings that were of -A$31.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cocrystal Pharma from 2008 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$15.31 Million-42.89%
2024 -A$26.81 Million-15.51%
2023 -A$31.73 Million16.66%
2022 -A$27.2 Million27.9%
2021 -A$21.27 Million47.11%
2020 -A$14.46 Million-79.98%
2019 -A$72.19 Million-22.92%
2018 -A$93.66 Million651.62%
2017 -A$12.46 Million-92.14%
2016 -A$0.16 Billion96.12%
2015 -A$80.88 Million830.46%
2014 -A$8.7 Million18.04%
2013 -A$7.37 Million95.95%
2012 -A$3.76 Million-31.98%
2011 -A$5.53 Million
2009 -A$0.07 Million-23.29%
2008 -A$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
A$34.61 B-236,484.11%๐Ÿ‡บ๐Ÿ‡ธ USA
USANA
USNA
A$72.9 M-597.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.56 B-331,754.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Nature's Sunshine Products
NATR
A$41.11 M-380.74%๐Ÿ‡บ๐Ÿ‡ธ USA